ISPOR Europe 2026
Panel Patient-Centered Evidence track
COAlescing the Oncology COA Strategy: A Provocative Look at Why Oncology COA Strategies Often Fail - and How to Fix Them
Mon, Nov 9, 2026 · 1:45–2:45 PM CET Hall G1, Level -2, Austria Center Vienna
About this session
Issue Clinical Outcome Assessments (COAs) are central to patient-centered oncology trials and regulatory decision-making, yet many COA strategies fail to produce interpretable or label-enabling evidence. A key reason is that COAs are too often treated as downstream measurement tools rather than integral parts of trial design.
Speakers
-
IQVIA
Panelist
